Rowland Charles A Jr

Director at VKTX; Director at Nabriva Therapeutics AG; Director at BPMC, and 1 more

Sold, on record
$9.8M
Dollars the filings state
Form 4 sales
9
Latest Oct 27, 2025
Form 144 notices
2
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale BPMCUnusual
    Nov 3, 2020 2020

    Sold 10,000 shares at $98.90 ($989k)

    Rowland Charles A Jr, Director

    Sold 73.7% of holdings ($1.3M position)3,562 shares leftFiling

  2. 2 Form 4 sale BPMCUnusual
    Dec 17, 2020 +44 days

    Sold 10,909 shares at $117.82 ($1.3M)

    Rowland Charles A Jr, Director

    Sold 75.4% of holdings ($1.7M position)3,562 shares leftFiling

  3. 3 Form 4 sale Nabriva Therapeutics AGPlan not stated
    Aug 2, 2021 +228 days

    Sold 777 shares at $1.20 ($932)

    Rowland Charles A Jr, Director

    Sold 3.2% of holdings ($29k position)23,773 shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Nabriva Therapeutics AGUnusual
    Aug 1, 2022 +364 days

    Sold 8,496 shares at $0.18 ($2k)

    Rowland Charles A Jr, Director

    Sold 35.7% of holdings ($4k position)15,277 shares leftFiling

  5. 5 Form 144 notice VKTXNotice
    May 16, 2023 +288 days

    Filed to sell 40,000 shares ($1M)

    Rowland Charles A Jr, Director

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale VKTXUnusual
    May 16, 2023 same day

    Sold 40,000 shares at $25.00 ($1M)

    Rowland Charles A Jr, Director

    No 10b5-1 planSold 57.1% of holdings ($1.8M position)30,000 shares leftFirst sale on recordFiling

  7. 7 Form 144 notice VKTXNotice
    Oct 27, 2025 +895 days

    Filed to sell 60,000 shares ($2.1M)

    Rowland Charles A Jr, Director

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 sale VKTXUnusual
    Oct 27, 2025 same day

    Sold 60,000 shares at $35.57 ($2.1M)

    Rowland Charles A Jr, Director

    No 10b5-1 planSold 66.7% of holdings ($3.2M position)30,000 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (11)

Form 144 notices and Form 4 sales by Rowland Charles A Jr
Source
Oct 27, 2025Oct 28, 2025VKTXDirectorForm 4 sale60,000$2.1M66.7%UnusualSEC
Oct 27, 2025Oct 27, 2025VKTXDirectorForm 144 notice60,000$2.1MNoticeSEC
May 16, 2023May 18, 2023VKTXDirectorForm 4 sale40,000$1M57.1%UnusualSEC
May 16, 2023May 16, 2023VKTXDirectorForm 144 notice40,000$1MNoticeSEC
Aug 1, 2022Aug 3, 2022Nabriva Therapeutics AGDirectorForm 4 sale8,496$2k35.7%UnusualSEC
Aug 2, 2021Aug 4, 2021Nabriva Therapeutics AGDirectorForm 4 sale777$9323.2%Plan not statedSEC
Dec 17, 2020Dec 18, 2020BPMCDirectorForm 4 sale10,909$1.3M75.4%UnusualSEC
Nov 3, 2020Nov 4, 2020BPMCDirectorForm 4 sale10,000$989k73.7%UnusualSEC
Jun 20, 2019Jun 24, 2019BPMCDirectorForm 4 sale11,818$1.1M100.0%UnusualSEC
Mar 1, 2012Mar 5, 2012VIROPHARMA INCVP, Chief Financial OfficerForm 4 sale82,750$2.7M82.9%UnusualSEC
Mar 14, 2011Mar 15, 2011VIROPHARMA INCVP, Chief Financial OfficerForm 4 sale35,000$650k55.1%UnusualSEC